SBIR/STTR Research Award

Stem cell toxicology assays for cardiac differentiation

Award identifier a390ad55b74a97a773704be5ff6d3b18e6209a3be68748b21c78f2331cb1e5c8Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,499,999

Program and phase

SBIR · Phase II

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
VALA SCIENCES, INC.
Proposal award date
2016-03-01
Contract end date
2018-08-31
UEI
CZZJVX2BKJF3
Solicitation number
ES15-006
Topic code
NIEHS

Research abstract

DESCRIPTION provided by applicant Defects in heart formation during embryonic and fetal development likely contribute to miscarriages which terminate up to of all pregnancies and Congential Heart Defects CHDs which are among the most common birth defects Environmental factors may influence miscarriages and up to of all CHDs but little is known about how such chemicals affect formation of the heart during early embryonic differentiation The goal of this SBIR project is to develop a Cardiopoiesis Assay heart formation assay to enable testing of compounds to determine if they influence the emergence of cardiac myocytes from multipotent mesodermal progenitors a critical early decision point in heart formation During the previous Phase I portion of the project a version of the assay was developed using mouse embryonic stem cells and this assay has proven useful in identifying chemicals siRNAs and miRs that modify cardiac differentiation For Phase II we propose to develop the assay using human induced pluripotent stem cells hiPSCs which will be derived from multiple donors to increase the genetic diversity represented by the assay The Cardiopoiesis Assay will be useful in predicting whether chemical compounds affect heart formation in the human embryo which is of critical importance to human health The assay will be of interest to government agencies in the US such as the Environmental Protection Agency and worldwide concerned with environmental toxicology PUBLIC HEALTH RELEVANCE Defects of the heart are the most common birth defects and may be caused in part by toxic compounds from the environment that interfere with heart formation prior to birth We propose to develop a test system to screen chemicals for dangerous effects on heart formation We propose to use human stem cells which we will derive from skin samples obtained from volunteer donors the skin samples are obtained by a painless procedure that is risk free Such stem cells can be cultured in a manner that they form beating heart cells in laboratory dishes We will develop a procedure to test if chemicals prevent formation of heart cells from stem cells as such chemicals are likely to cause heart birth defects

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

37 SBIR/STTR records share this UEI (2006–2024). Reported award amounts total $27,661,877. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.